BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9150947)

  • 1. Renal cell carcinoma and normal kidney protein expression.
    Sarto C; Marocchi A; Sanchez JC; Giannone D; Frutiger S; Golaz O; Wilkins MR; Doro G; Cappellano F; Hughes G; Hochstrasser DF; Mocarelli P
    Electrophoresis; 1997; 18(3-4):599-604. PubMed ID: 9150947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
    Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
    Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modified expression of plasma glutathione peroxidase and manganese superoxide dismutase in human renal cell carcinoma.
    Sarto C; Frutiger S; Cappellano F; Sanchez JC; Doro G; Catanzaro F; Hughes GJ; Hochstrasser DF; Mocarelli P
    Electrophoresis; 1999 Nov; 20(17):3458-66. PubMed ID: 10608715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential protein profiling in renal-cell carcinoma.
    Shi T; Dong F; Liou LS; Duan ZH; Novick AC; DiDonato JA
    Mol Carcinog; 2004 May; 40(1):47-61. PubMed ID: 15108329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific reduction of fas-associated protein with death domain (FADD) in clear cell renal cell carcinoma.
    Xu H; He L; Feng X; Kapoor A; Tang D
    Cancer Invest; 2009 Oct; 27(8):836-43. PubMed ID: 19557578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precancerous lesions in the kidney.
    Van Poppel H; Nilsson S; Algaba F; Bergerheim U; Dal Cin P; Fleming S; Hellsten S; Kirkali Z; Klotz L; Lindblad P; Ljungberg B; Mulders P; Roskams T; Ross RK; Walker C; Wersäll P
    Scand J Urol Nephrol Suppl; 2000; (205):136-65. PubMed ID: 11144893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Image analysis of proliferating cell nuclear antigen expression and immunohistochemical profiles in renal cell carcinoma associated with acquired cystic kidney disease: comparison with classic renal cell carcinoma.
    Khurana KK; Truong LD; Verani RR
    Mod Pathol; 1998 Apr; 11(4):339-46. PubMed ID: 9578084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Differential analysis of two-dimension gel electrophoresis profiles of human lung squamous carcinoma and tumor-adjacent tissue].
    Li C; Chen ZC; Xiao ZQ; Wu XY; Zhan XQ; Li MY; Feng XP; Zhang XP; Li JL; Chen P; Liang SP
    Ai Zheng; 2004 Jan; 23(1):28-35. PubMed ID: 14720370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of nuclear matrix protein alterations associated with renal cell carcinoma.
    Konety BR; Nangia AK; Nguyen TS; Veitmeier BN; Dhir R; Acierno JS; Becich MJ; Hrebinko RL; Getzenberg RH
    J Urol; 1998 Apr; 159(4):1359-63. PubMed ID: 9507884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of heat shock protein-27 expression in patients with renal cell carcinoma.
    Erkizan O; Kirkali G; Yörükoğlu K; Kirkali Z
    Urology; 2004 Sep; 64(3):474-8. PubMed ID: 15351573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The human T-cell factor-4 gene splicing isoforms, Wnt signal pathway, and apoptosis in renal cell carcinoma.
    Shiina H; Igawa M; Breault J; Ribeiro-Filho L; Pookot D; Urakami S; Terashima M; Deguchi M; Yamanaka M; Shirai M; Kaneuchi M; Kane CJ; Dahiya R
    Clin Cancer Res; 2003 Jun; 9(6):2121-32. PubMed ID: 12796377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the expression of HLA class I, proinflammatory cytokines and chemokines in primary tumors from patients with localized and metastatic renal cell carcinoma.
    Romero JM; Aptsiauri N; Vazquez F; Cozar JM; Canton J; Cabrera T; Tallada M; Garrido F; Ruiz-Cabello F
    Tissue Antigens; 2006 Oct; 68(4):303-10. PubMed ID: 17026465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary cell cultures arising from normal kidney and renal cell carcinoma retain the proteomic profile of corresponding tissues.
    Perego RA; Bianchi C; Corizzato M; Eroini B; Torsello B; Valsecchi C; Di Fonzo A; Cordani N; Favini P; Ferrero S; Pitto M; Sarto C; Magni F; Rocco F; Mocarelli P
    J Proteome Res; 2005; 4(5):1503-10. PubMed ID: 16212400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-dimensional gel electrophoresis of Escherichia coli homogenates: the Escherichia coli SWISS-2DPAGE database.
    Pasquali C; Frutiger S; Wilkins MR; Hughes GJ; Appel RD; Bairoch A; Schaller D; Sanchez JC; Hochstrasser DF
    Electrophoresis; 1996 Mar; 17(3):547-55. PubMed ID: 8740179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered expression of beta-catenin in renal cell cancer and transitional cell cancer with the absence of beta-catenin gene mutations.
    Bilim V; Kawasaki T; Katagiri A; Wakatsuki S; Takahashi K; Tomita Y
    Clin Cancer Res; 2000 Feb; 6(2):460-6. PubMed ID: 10690524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of transcript for brain-type fatty Acid-binding protein in tumor and urine of patients with renal cell carcinoma.
    Teratani T; Domoto T; Kuriki K; Kageyama T; Takayama T; Ishikawa A; Ozono S; Nozawa R
    Urology; 2007 Feb; 69(2):236-40. PubMed ID: 17320655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of t(6;11)(p21;q12) in a renal-cell carcinoma of an adult patient.
    Pecciarini L; Cangi MG; Lo Cunsolo C; Macri' E; Dal Cin E; Martignoni G; Doglioni C
    Genes Chromosomes Cancer; 2007 May; 46(5):419-26. PubMed ID: 17285572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic organization and chromosomal localization of the human CUL2 gene and the role of von Hippel-Lindau tumor suppressor-binding protein (CUL2 and VBP1) mutation and loss in renal-cell carcinoma development.
    Clifford SC; Walsh S; Hewson K; Green EK; Brinke A; Green PM; Gianelli F; Eng C; Maher ER
    Genes Chromosomes Cancer; 1999 Sep; 26(1):20-8. PubMed ID: 10441001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An integrated physical and gene map of the 3.5-Mb chromosome 3p21.3 (AP20) region implicated in major human epithelial malignancies.
    Protopopov A; Kashuba V; Zabarovska VI; Muravenko OV; Lerman MI; Klein G; Zabarovsky ER
    Cancer Res; 2003 Jan; 63(2):404-12. PubMed ID: 12543795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FHIT gene and the FRA3B region are not involved in the genetics of renal cell carcinomas.
    Bugert P; Wilhelm M; Kovacs G
    Genes Chromosomes Cancer; 1997 Sep; 20(1):9-15. PubMed ID: 9290948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.